CLINICAL_TRIALS
trial_result
· 2014-07-04
Clinical Trial Update: Post-operative or Early Salvage XRT and ADT for High Risk PCa [Phase 3]
Summary
A Phase 3 trial evaluating post-operative or early salvage radiotherapy with androgen deprivation therapy for high-risk prostate cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED